Registration and Activity Links - CARDIOLOGY -
SURVIVE™ (Strategies for Urgent Reperfusion of Vessels in Vascular Emergencies)
SURVIVE™ Distinguished Lectures
The following 1 hour CME lectures, now being offered to hospitals nationwide:
1. Reperfusion Strategies in Patients With STEMI
2. STEMI Management: An Emergency Department Perspective
3. Management of Patients with STEMI: Applying the ACC/AHA
After taking part any of these three activities, participants should be better able to:
- Discuss the epidemiology and pathophysiology associated with ST-segment-elevation MI (STEMI)
- Summarize ACC/AHA recommendations for choosing fibrinolysis vs PCI in managing patients with STEMI
- Describe key trials that support current ACC/AHA guidelines for STEMI
If you are interested in scheduling a SURVIVE™ CME Distinguished Lectures (Grand Rounds) program at your institution, click here.
SURVIVE™ CME/CE Teleconferences
Reperfusion Strategies in Patients With STEMI
Program Description
Reperfusion strategies with either fibrinolytics or percutaneous coronary intervention (PCI) should be considered for every patient having symptoms of ST-segment elevation myocardial infarction (STEMI). In this live, interactive teleconference series, experts from the SURVIVE Scientific Council discuss critical decisions in the care of patients with STEMI. Topics include when to choose fibrinolysis or PCI, comparative features of approved fibrinolytic agents, the use of transfer protocols at hospitals without catheterization laboratories, results from trials on combined mechanical and pharmacologic reperfusion, and adjunctive treatment with thienopyridines, glycoprotein IIb/IIIa inhibitors, or low molecular weight heparin depending on the primary reperfusion strategy used. Practical advice for implementing the current ACC/AHA STEMI guidelines in the hospital and an opportunity to "ask the experts" provide a comprehensive learning experience.
Learning Objectives
After taking part in this activity, participants should be better able to:
- Summarize ACC/AHA recommendations for choosing fibrinolysis or PCI in managing patients with STEMI
- Outline pharmacologic and mechanical reperfusion strategies, including fibrinolytic dosing, timing of reperfusion, and transfer protocols for hospitals with and without catheterization labs
- Describe key findings from trials that support current ACC/AHA guidelines for STEMI
- Develop critical pathways for managing patients with STEMI based on the ACC/AHA guidelines
Intended Audience
This CME/CE activity is designed for emergency medicine physicians, cardiologists, interventional cardiologists, critical care physicians, intensivists, pharmacists, critical care nurses, and other healthcare professionals who provide care to patients with cardiovascular disease.
Faculty
Eric R. Bates, MD
Professor of Internal Medicine
Division of Cardiovascular Diseases
University of Michigan Medical School
Ann Arbor, Michigan
Christopher P. Cannon, MD
Associate Professor of Medicine
Harvard Medical School
Senior Investigator, TIMI Study Group
Associate Physician, Cardiovascular Division
Brigham and Women’s Hospital
Boston, Massachusetts
David M. Janicke, MD, PhD
Associate Professor of Emergency Medicine
State University of New York at Buffalo
Research Director
Professional Emergency Services, PLLC
Buffalo, New York
W. Frank Peacock, MD
Vice Chief, Emergency Cardiology Research
Department of Emergency Medicine
The Cleveland Clinic Foundation
Cleveland, Ohio
Robert Talbert, PharmD
Professor and Division Head
Division of Pharmacotherapy
University of Texas Health Science Center
San Antonio, Texas
University of Texas at Austin College of Pharmacy
Austin, Texas
Click here to register for a date and time convenient for you.
